-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Continuously advancing the internationalization strategy (Phase I) | Keyuan Pharmaceutical's International Marketing Team Heads to Southeast Asia for Market Exchange and Research!
Publish Time:
2024-08-05
Recently, the international marketing team of Keyuan Pharmaceutical successfully concluded its exchange and research activities in the Southeast Asian market. Led by Chairman and President Jiang Hongsheng and Director of International Trade Shi Bin, the initiative included visits to existing clients, development of new business relationships, and exploration of market opportunities. These efforts not only deepened Keyuan Pharmaceutical's understanding and communication with the Southeast Asian market but also laid a solid foundation for the company to further expand its international operations.
Recently, the international marketing team of Keyuan Pharmaceutical successfully concluded its exchange and research activities in the Southeast Asian market. Led by Chairman and President Jiang Hongsheng and Director of International Trade Shi Bin, the initiative included visits to existing clients, development of new business relationships, and exploration of market opportunities. These efforts not only deepened Keyuan Pharmaceutical's understanding and communication with the Southeast Asian market but also laid a solid foundation for the company to further expand its international business.
As an important component of the global pharmaceutical market, Southeast Asia boasts tremendous growth potential and vast market opportunities. To actively align with the nation’s “Belt and Road” initiative and expand its share in international trade, Keyuan Pharmaceutical has consistently prioritized the Southeast Asian market as a key region for its internationalization strategy, pursuing deep and sustained expansion there.
During the调研 period, the international marketing team conducted on-site visits to several key partner pharmaceutical companies, potential major clients, and retail pharmacies. Through face-to-face interactions and discussions, the company gained a deep understanding of local market demands and characteristics, while also fostering closer relationships with both existing and new customers. This has laid a solid foundation for expanding business into the Southeast Asian market and provided valuable insights to support the ongoing advancement of the company’s global strategy.
As a leading enterprise in China's niche segment of chemical APIs, Keyuan Pharmaceutical has consistently been committed to advancing its journey toward capitalization and internationalization. The company remains steadfastly market-oriented and innovation-driven, continuously enhancing both product quality and service standards.
In the international market, Keyuan Pharmaceutical has deepened cooperation with numerous domestic and overseas pharmaceutical companies and research institutions through various approaches, including expanding export operations, fostering economic and trade capacity collaboration, and promoting industrial and technological partnerships—jointly driving the prosperity and growth of the pharmaceutical industry.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline